Merck says US CDC endorses cervical cancer vaccine

	Tweet

Merck & Co. Thursday said the U.S. Centers for Disease Control and Prevention has adopted the recommendation of an advisory panel that the drugmaker’s vaccine against cervical cancer routinely be given to females aged 11 through 26.

The recommendations for use of the Gardasil vaccine, which provides protection against two strains of the human papillomavirus responsible for most cases of cervical cancer, were issued by the FDA’s Advisory Committee on Immunization Practices in June 2006. 

"The guidelines state that routine vaccination with Gardasil is recommended for 11- and 12-year-old females and for females ages 13 to 26 who have not previously been vaccinated or who have not completed the full series, and that vaccination with Gardasil can be started at nine years of age,” Merck said in a news release.

RELATED STORIES:
1-visit screening, prevention for cervical cancer holds promise   Merck cervical cancer shot gives 5-year protection   Obese women in Canada are less likely to be screened for cervical cancer   Cervical cancer vaccine gives long protection   High HPV Concentrations, Smoking Significantly Raise Risks of Cancer   Phenoxodiol Produces Anti-cancer Responses in Women with Cervical Cancer   Smoking increases risk cervical cancer   HIV drug stops cervical cancer in laboratory test   HPV Vaccine Reduces Abnormal Pap Test Results   New MRI technique may identify cervical cancer early   Cervical cancer screening rates low in poor areas   Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types   Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia   New cervical cancer test increases the detection rate of abnormal cells   Cervical cancer screening: Too many are left unprotected   Women with AIDS face cervical cancer threat   HPV Clearance Tied to Cervical Cancer Disparity   Gardasil prevents cervical cancer caused by virus   Aggressive vaccine effort could cut cervical cancer   Health panel cautious on HPV screening vs Pap   Weakened RNA Interference Reduces Survival in Ovarian Cancer   Virus causes rare form of cervical cancer too

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]